Lipids in health and disease

Biochemical Society Transactions

Volumn 32, Issue 6, 2004, Pages 1051-1056

  Shepherd, J ^a  

^a GLASGOW ROYAL INFIRMARY   (United Kingdom)

Author keywords

Cardiovascular disease; Cholesterol absorption; Cholesterol synthesis; Ezetirnibe; HMG CoA reductase inhibitors (statins); Lipids

Indexed keywords

ANTILIPEMIC AGENT; ATORVASTATIN; CHOLESTEROL; CHOLESTEROL ABSORPTION INHIBITOR; DRUG METABOLITE; EZETIMIBE; EZETIMIBE GLUCURONIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; HYPOCHOLESTEROLEMIC AGENT; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MEVINOLIN; PRAVASTATIN; SIMVASTATIN; UNCLASSIFIED DRUG;

ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL METABOLISM; CLINICAL TRIAL; CONFERENCE PAPER; DISORDERS OF LIPID AND LIPOPROTEIN METABOLISM; DOSE RESPONSE; DRUG EFFICACY; DRUG MECHANISM; DRUG RESPONSE; DRUG STRUCTURE; HEALTH; HUMAN; HYPERCHOLESTEROLEMIA; NONHUMAN; PRIORITY JOURNAL; VASCULAR DISEASE;

ANTICHOLESTEREMIC AGENTS; AZETIDINES; CHOLESTEROL, LDL; DISEASE; HEALTH; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERLIPIDEMIAS; LIPIDS; LIVER;

EID: 10644293873     PISSN: 03005127     EISSN: None     Source Type: Journal    
DOI: 10.1042/BST0321051     Document Type: Conference Paper

References (35)

1. Roberts, W.C. (1996) Am. J. Cardiol. 78, 377-378
2. The Scandinavian Simvastatin Survival Study Group (1994) Lancet 344, 1383-1389
3. Shepherd, J., Cobbe, S.M., Ford, L, Isles, E.G., Lorimer, A.R., Macfarlane, P.W., McKillop, J.H. and Packard, C.J. (for the West of Scotland Coronary Prevention Study Group) (1995) N. Engl. J. Med. 333, 1301-1307
4. Sacks, P.M., Pfeffer, M.A., Moye, L.A., Rouleau, J.L., Rutherford, J.D., Cole, T.G., Brown, L., Warnica, J.W., Arnold, J.M., Wun, C.-C. et al. (1996) N. Engl. J. Med. 335, 1001-1009
5. Long-Term Intervention with Pravastatin in Ischemic Disease (LIPID) Study Group (1998) N. Engl. J. Med. 339, 1349-1357
6. Downs, J.R., Clearfield, M., Weis, S., Whitney, E., Shapiro, D.R., Beere, P.A., Langendorfer, A., Stein, EA, Kruyer, W. and Gotto, Jr, A.M. (for the AFCAPS/TexCAPS Research Group) (1998) JAMA 279, 1615-1622
7. Heart Protection Study Collaborative Group (2002) Lancet 360, 7-22
8. Sever, P.S., Dahlof, B., Poulter, N.R. et al. (2003) Lancet 361, 1149-1158
9. Shepherd, J., Blauw, G.J., Murphy, M.B. et al. (2002) Lancet 360, 1623-1630
10. Brown, M.S. and Goldstein, J.L (1997) Cell (Cambridge, Mass.) 89, 331-340
11. Norton, J.D. and Shimomura, I. (1999) Curr. Opin. Lipidol. 10, 143-150
12. Edwards, P.A. and Ericsson, J. (1998) Curr. Opin. Lipidol. 9, 433-440
13. Shepherd, J., Packard, C.J., Bicker, S., Lawrie, T.D.V. and Morgan, H.G. (1980) N. Engl. J. Med. 302, 1219-1222
14. Gaw, A., Packard, C.J., Murray, E.F. et al. (1993) Arterioscler. Thromb. 13, 170-189
15. Dujovne, CA (1997) Curr. Opin. Lipidol. 8, 362-368
16. Patrick, J.E., Kosoglou, T., Stauber, K.L., Alton, K.B., Maxwell, S.E., Zhu, Y., Statkevich, P., Lannucci, R., Chowdhury, S., Affrime, M. et al. (2002) Drug Metab. Dispos. 30, 430-437
17. Zhu, Y., Statkevich, P., Schuessler, D., Maxwell, S.E., Patrick, J., Kosoglou, T. and Batra, V. (2000) AAPS Pharm. Sci. 2 (Suppl. 4), 2660 (Abstract)
18. Reference deleted
19. Turley, S.D. and Dietschy, J.M. (1988) In The Liven Biology and Pathobiology (Arias, I.M., Jakoby, W.B., Popper, H., Schachter, D. and Shafritz, O.A., eds.), pp. 617-641, Raven Press, New York
20. Turley, S.D. (1999) Eur. Heart J. Suppl. 1 (Suppl. 5), 529-535
21. Clarke, R., Frost, C., Collins, R., Appleby, P. and Peto, R. (1997) Br. Med. J. 314, 112-117
22. Howell, W.H., McNamara, D.J., Tosca, MA, Smith, B.T. and Gaines, J.A. (1997) Am. J. Clin. Nutr. 65, 1747-1764
23. Sudhop, T., Lutjohann, D., Kodal, A., Igel, M., Tribble, D.L., Shah, S., Perevozskaya, I. and von Bergmann, K. (2002) Circulation 106, 1943-1948
24. Frick, W., Bauer-Schafer, A., Bauer, J., Girbig, F., Corsiero, D., Heuer, H. and Kramer, W. (2003) Bioorg. Med. Chem. 11, 1639-1642
25. Sudhop, T. and von Bergmann, K. (2002) Drugs 62, 2333-2347
26. Van Heek, M., Parley, C, Compton, D.S., Hoos, L., Alton, K.B., Sybertz, E.J. and Davis, Jr, H.R. (2000) Br. J. Pharmacol. 129, 1748-1754
27. Van Heek, M., Parley, C, Compton, D.S., Hoos, L.M., Smith-Torhan, A. and Davis, H.R. (2003) Br. J. Pharmacol. 138, 1459-1464
28. Altmann, S.W., Davis, H.R., Yao, X., Laverty, M., Compton, D.S., Zhu, LJ., Crona, J.H., Caplen, MA, Hoos, L.M., Tetzloff, G. et al. (2002) Biochim. Biophys. Acta 1580, 77-93
29. Altmann, S.W., Davis, H.R., Zhu, L., Yao, X., Hoos, L.M., Tetzloff, G., Iyer, S.P.N., Maguire, M., Golovko, A, Zeng, M. et al. (2004) Science 3003, 1201-1204
30. Kosoglou, T., Meyer, L, Veltri, E.P., Statkevich, P., Yang, B., Zhu, Y., Mellars, L., Maxwell, S.E., Patrick, J.E., Cutler, D.L. et al. (2002) Br. J. Pharmacol. 54, 309-319
31. Kerzner, B., Corbelli, J., Sharp, S., Lipka, L.J., Melani, L., Le Beaut, A., Suresh, R., Mukhopadhyay, P. and Veltri, E.P. (2003) Am. J. Cardiol. 91, 418-424
32. Melani, L., Mills, R., Hassman, D., Pipetz, R., Lipka, L.J., Le Beaut, A., Suresh, R., Mukhopadhyay, P. and Veltri, E.P. (2003) Eur. Heart J. 24, 717-728
33. Davidson, M.H., McGarry, T., Bettis, R., Melani, L., Lipka, L.J., Le Beaut, A., Suresh, R., Sun, S. and Veltri, E.P. (2002) JACC 40, 2125-2134
34. Ballantyne, C.M., Houri, J., Nortabartolo, A., Melani, L., Lipka, L.J., Suresh, R., Sun, S., Le Beaut, A., Sager, P.T. and Veltri, E.P. (2003) Circulation 107, 2409-2415
35. Sager, P.T., Melani, L., Lipka, L., Strony, J., Yang, B., Suresh, R. and Veltri, E. (Ezetimibe Study Group) (2003) Am. J. Cardiol. 92, 1414-1418